Addition of cetuximab to first-line chemotherapy in patients with advanced non-small-cell lung cancer: a cost-utility analysis
Markus Joerger, K Matter-Walstra , Martin Früh, U Kühnel , T Szucs , B Pestalozzi & M Schwenkglenks
|
keywords
|
Addition of cetuximab to first-line chemotherapy in patients with advanced non-small-cell lung cancer: a cost-utility analysis. |
| |
|
|
citation
|
Joerger M, Matter-Walstra K, Früh M, Kühnel U, Szucs T,
Pestalozzi B, Schwenkglenks M. Addition of cetuximab to first-line
chemotherapy in patients with advanced non-small-cell lung cancer: a
cost-utility analysis. Ann Oncol 2012; 22:567-574.
|
| |
|
|
type
|
journal paper/review (English)
|
|
date of publishing
|
4-1-2012
|
|
journal title
|
Ann Oncol (22/3)
|
|
pages
|
567-574
|
|
contact
|
Markus Joerger
|
additional links & downloads
